Cargando…

Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis

Leishmaniasis encompasses a group of diseases caused by protozoan parasites belonging to the genus Leishmania. These diseases range from life threatening visceral forms to self-healing cutaneous lesions, and each disease manifestations can progress to complications involving dissemination of parasit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Rajiv, Chauhan, Shashi Bhushan, Ng, Susanna S., Sundar, Shyam, Engwerda, Christian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682306/ https://www.ncbi.nlm.nih.gov/pubmed/29167671 http://dx.doi.org/10.3389/fimmu.2017.01492

Ejemplares similares

Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination
por: Kumar, Awnish, et al.
Publicado: (2023)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2016)

An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2022)

Vaccines to prevent leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2014)

The Role of IL-10 in Malaria: A Double Edged Sword
por: Kumar, Rajiv, et al.
Publicado: (2019)

Unraveling the Role of Immune Checkpoints in Leishmaniasis
por: de Freitas e Silva, Rafael, et al.
Publicado: (2021)

Host-Directed Therapies for Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2021)

Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis
por: Bunn, Patrick T., et al.
Publicado: (2017)

Immune Regulation during Chronic Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2014)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

The Regulation of CD4(+) T Cell Responses during Protozoan Infections
por: Engwerda, Christian R., et al.
Publicado: (2014)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2020)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Increased amphiregulin expression by CD4(+) T cells from individuals with asymptomatic Leishmania donovani infection
por: Singh, Siddharth Sankar, et al.
Publicado: (2022)

Immune checkpoint molecules in prevention and development of asthma
por: Kanannejad, Zahra, et al.
Publicado: (2023)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer
por: Looney, Timothy John, et al.
Publicado: (2020)

Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice
por: Eichenberger, Ramon M., et al.
Publicado: (2018)

Drug Resistance in Leishmaniasis
por: Chakravarty, Jaya, et al.
Publicado: (2010)

Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
por: Krug, Stefanie, et al.
Publicado: (2021)

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
por: Anzar, Irantzu, et al.
Publicado: (2023)

Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions
por: Chen, Jiao-Ting, et al.
Publicado: (2023)

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012)

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)

Protective and pathologic immune responses in human tegumentary leishmaniasis
por: Carvalho, Lucas P., et al.
Publicado: (2012)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

Modulation of innate immunity in airway epithelium for host-directed therapy
por: Myszor, Iwona T., et al.
Publicado: (2023)

Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Xu, Shuo, et al.
Publicado: (2021)

The Role of BACH2 in T Cells in Experimental Malaria Caused by Plasmodium chabaudi chabaudi AS
por: Edwards, Chelsea L., et al.
Publicado: (2018)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis
por: de Freitas, Elisangela Oliveira, et al.
Publicado: (2016)

Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021)

It takes two to tango: the role of tumor-associated macrophages in T cell-directed immune checkpoint blockade therapy
por: Sheban, Fadi
Publicado: (2023)

Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention
por: Brooks, Lavida R. K., et al.
Publicado: (2018)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)

Editorial: Immunometabolic Regulations in Adaptive and Innate Immune Cells Shapes and Re-Directs Host Immunity
por: Ho, Ping-Chih, et al.
Publicado: (2017)

Function of Macrophage and Parasite Phosphatases in Leishmaniasis
por: Soulat, Didier, et al.
Publicado: (2017)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
por: Zhou, Jiaxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idb29t7bh3r0k3pj7onvs4h08r